Roche files for covid-19 drug

The chemical and pharmaceuticals company Roche has filed an order for the emergency use of a medicine, according to Covid-19, the National Health Surveillance Agency (Anvisa) said yesterday, 2, which will evaluate the request within 30 days, if it is not necessary to ask for additional documentation to complete the technical analysis.

According to a press release, the drug is the result of the combination of two biological drugs (casirivimab + imdevimab). Anvisa informs that the first 72 hours will be used to screen the process and check if the necessary documents are available.

+ Doubts about possible side effects of the AstraZeneca vaccine increase
+ Celso de Mello congratulates Fux for vaccination against ‘obscurantist minds’

Roche delivered 3,626 pages of data and information about the drug. If important information is missing, Anvisa can ask the laboratory. To make the assessment, Anvisa will use the technical report issued by the American authority (Food and Drug Administration – FDA).

According to information available on the Roche group’s website, the cocktail of drugs against Covid was tested on approximately 23,000 people in clinical trials conducted in February 2021. The trials were conducted on outpatients and certain hospitalized patients, including the open trial. in hospitalized patients in the UK and a trial for the prevention of covid-19.

See too

+ Career of the Decade – See how to enter the career that professionals lack, but vacancies

+ Trick to squeeze lemons becomes a craze on social media

+ Woman pretends to be FBI agent to get free food and goes to jail

+ Digital Blue Zone in SP changes on the 16th; see how it looks

+ Study reveals the healthiest method for cooking rice

+ Can belching a lot be a health problem?

+ Shark is captured in MA with remains of young people missing in the stomach

+ Cinema, sex and the city

+ Discovered 6,500-year-old copper workshop in the desert in Israel